Lin Fang-An, Hwang Lee-Ching, Tsou Meng-Ting, Huang Wei-Hsin
Department of Family Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
Department of Medicine, Mackay Medical College, Taipei, Taiwan.
Diabetes Metab Syndr Obes. 2023 Sep 15;16:2835-2842. doi: 10.2147/DMSO.S425651. eCollection 2023.
This study aimed to determine the incidence of metabolic syndrome (MetS) and its predictors in older patients with nonalcoholic fatty liver disease.
This retrospective cohort study analyzed repeated health surveillance data collected between 2009 and 2018 at Mackay Memorial Hospital, Taiwan. MetS was defined based on the modified National Cholesterol Education Program Adult Treatment Panel III (Taiwan revision). Participants were diagnosed with fatty liver disease using abdominal ultrasonography. The exclusion criteria included age <65 years, having viral hepatitis, frequent alcohol consumption, and pre-existing MetS. Logistic regression analysis was conducted, adjusting for sex and age.
We enrolled 758 older participants; 457 (60.3%) with preexisting metabolic syndrome were excluded. We studied the remaining 301 participants (39.7%), with a mean age of 71.3 ± 5.4 years. The cumulative incidence of MetS was 43.5% after a mean follow-up period of 4.2 years; moreover, it was higher in women as well as in participants with diabetes and hypertriglyceridemia. After adjusting for age and sex, we identified the following risk factors for MetS: baseline high fasting plasma glucose levels (adjusted odds ratio [aOR] =1.75; 95% confidence interval [CI] 1.03-2.95), baseline hypertriglyceridemia (aOR = 2.26; 95% CI 1.15-4.47), and baseline large waist circumference (aOR =1.71; 95% CI 1.01-2.89). Furthermore, increased waist circumference and fasting plasma glucose levels at follow-up were significant risk factors.
There is a high incidence of MetS among older individuals with nonalcoholic fatty liver disease; further, women and individuals with diabetes or hypertriglyceridemia are at risk of developing MetS. Moreover, waist circumference and fasting plasma glucose levels were positively associated with the risk of MetS.
本研究旨在确定老年非酒精性脂肪性肝病患者代谢综合征(MetS)的发病率及其预测因素。
这项回顾性队列研究分析了2009年至2018年期间在台湾马偕纪念医院收集的重复健康监测数据。MetS根据修改后的美国国家胆固醇教育计划成人治疗小组第三次报告(台湾修订版)进行定义。通过腹部超声检查诊断参与者是否患有脂肪性肝病。排除标准包括年龄<65岁、患有病毒性肝炎、频繁饮酒和既往已患MetS。进行逻辑回归分析,并对性别和年龄进行校正。
我们纳入了758名老年参与者;排除了457名(60.3%)既往患有代谢综合征的参与者。我们研究了其余301名参与者(39.7%),他们的平均年龄为71.3±5.4岁。平均随访4.2年后,MetS的累积发病率为43.5%;此外,女性以及患有糖尿病和高甘油三酯血症的参与者发病率更高。在对年龄和性别进行校正后,我们确定了以下MetS的危险因素:基线空腹血糖水平高(校正比值比[aOR]=1.75;95%置信区间[CI]1.03-2.95)、基线高甘油三酯血症(aOR = 2.26;95%CI 1.15-4.47)和基线腰围大(aOR =1.71;95%CI 1.01-2.89)。此外,随访时腰围增加和空腹血糖水平升高是显著的危险因素。
老年非酒精性脂肪性肝病患者中MetS的发病率较高;此外,女性以及患有糖尿病或高甘油三酯血症的个体有发生MetS的风险。而且,腰围和空腹血糖水平与MetS的风险呈正相关。